Will she tell her fellow Islanders about her past?

GLP-1 drugs may be rewiring circuits involved not only in appetite but in emotion, desire, and beyond. Ozempic may be reshaping the brain,...

A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

The ‘Taskmaster’ comedian, who is hosting the Bafta Television Awards on Sunday, said ‘three stone fell off me’ while using the drug

The number of bariatric surgeries performed annually in the U.S. has taken a sharp drop lately, new research shows, coinciding with the rise...

Parker Waichman, a national law firm, has now filed multiple lawsuits where each Plaintiff alleged that he or she developed NAION after taki...

Hershey’s CEO told stockholders that GLP-1 side effects are creating a ‘strong demand for gum.’

Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.

Retatrutide, often shortened to ‘reta’, is a peptide that researchers are still testing in clinical trials

Semaglutides like Ozempic (for diabetes) and Wegovy (for weight loss) have been in high demand in recent years, in large part because they a...

Weight-loss drugs turn food noise down, but it can be replaced by something far more disturbing. As the so-called ‘skinny epidemic’ shows up...

Retatrutide, often shortened to ‘reta’, is a peptide that researchers are still testing in clinical trials

Surgeons said social media is also behind changing demand for cosmetic procedures

Contrary to recent social media posts, GLP-1 drugs are not shredding away people's bones.